Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 1
1984 1
1985 3
1986 2
1987 7
1988 4
1989 1
1990 4
1991 10
1992 5
1993 2
1994 1
1995 6
1996 3
1997 6
1998 5
1999 4
2000 6
2001 5
2002 6
2003 9
2004 6
2005 3
2006 2
2007 7
2008 7
2009 6
2010 8
2011 5
2012 5
2013 10
2014 8
2015 11
2016 5
2017 5
2018 4
2019 3
2020 5
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

182 results
Results by year
Filters applied: . Clear all
Page 1
The Use of Anti-CD40 mAb in Cancer.
Remer M, White A, Glennie M, Al-Shamkhani A, Johnson P. Remer M, et al. Among authors: glennie m. Curr Top Microbiol Immunol. 2017;405:165-207. doi: 10.1007/82_2014_427. Curr Top Microbiol Immunol. 2017. PMID: 25651948 Review.
Rituximab: mechanisms and applications.
Johnson PW, Glennie MJ. Johnson PW, et al. Among authors: glennie mj. Br J Cancer. 2001 Nov 30;85(11):1619-23. doi: 10.1054/bjoc.2001.2127. Br J Cancer. 2001. PMID: 11742477 Free PMC article. Review. No abstract available.
Anti-CD20 monoclonal antibodies: historical and future perspectives.
Lim SH, Beers SA, French RR, Johnson PW, Glennie MJ, Cragg MS. Lim SH, et al. Among authors: glennie mj. Haematologica. 2010 Jan;95(1):135-43. doi: 10.3324/haematol.2008.001628. Epub 2009 Sep 22. Haematologica. 2010. PMID: 19773256 Free PMC article. Review.
Immunostimulatory monoclonal antibodies for cancer therapy.
Melero I, Hervas-Stubbs S, Glennie M, Pardoll DM, Chen L. Melero I, et al. Among authors: glennie m. Nat Rev Cancer. 2007 Feb;7(2):95-106. doi: 10.1038/nrc2051. Nat Rev Cancer. 2007. PMID: 17251916 Review.
FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs.
White AL, Chan HT, French RR, Beers SA, Cragg MS, Johnson PW, Glennie MJ. White AL, et al. Among authors: glennie mj. Cancer Immunol Immunother. 2013 May;62(5):941-8. doi: 10.1007/s00262-013-1398-6. Epub 2013 Mar 31. Cancer Immunol Immunother. 2013. PMID: 23543215 Review.
Signaling antibodies in cancer therapy.
Cragg MS, French RR, Glennie MJ. Cragg MS, et al. Among authors: glennie mj. Curr Opin Immunol. 1999 Oct;11(5):541-7. doi: 10.1016/s0952-7915(99)00010-2. Curr Opin Immunol. 1999. PMID: 10508709 Review.
182 results